Notice: This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends UPTD vs. TSBX, KLTO, OMGA, APTO, FRTX, CERO, TTNP, GENE, SCNI, and KRBPShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Turnstone Biologics (TSBX), Klotho Neurosciences (KLTO), Omega Therapeutics (OMGA), Aptose Biosciences (APTO), Fresh Tracks Therapeutics (FRTX), CERo Therapeutics (CERO), Titan Pharmaceuticals (TTNP), Genetic Technologies (GENE), Scinai Immunotherapeutics (SCNI), and Kiromic BioPharma (KRBP). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. Turnstone Biologics Klotho Neurosciences Omega Therapeutics Aptose Biosciences Fresh Tracks Therapeutics CERo Therapeutics Titan Pharmaceuticals Genetic Technologies Scinai Immunotherapeutics Kiromic BioPharma TradeUP Acquisition (NASDAQ:UPTD) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking. Do analysts prefer UPTD or TSBX? Turnstone Biologics has a consensus target price of $0.45, suggesting a potential upside of 27.08%. Given Turnstone Biologics' stronger consensus rating and higher probable upside, analysts clearly believe Turnstone Biologics is more favorable than TradeUP Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TradeUP Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Do insiders and institutionals hold more shares of UPTD or TSBX? 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by company insiders. Comparatively, 32.1% of Turnstone Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor UPTD or TSBX? Turnstone Biologics received 4 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTradeUP AcquisitionN/AN/ATurnstone BiologicsOutperform Votes444.44% Underperform Votes555.56% Does the media prefer UPTD or TSBX? In the previous week, Turnstone Biologics had 2 more articles in the media than TradeUP Acquisition. MarketBeat recorded 2 mentions for Turnstone Biologics and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat Turnstone Biologics' score of 0.43 indicating that TradeUP Acquisition is being referred to more favorably in the media. Company Overall Sentiment TradeUP Acquisition Positive Turnstone Biologics Neutral Is UPTD or TSBX more profitable? TradeUP Acquisition's return on equity of 0.00% beat Turnstone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets TradeUP AcquisitionN/A N/A -3.38% Turnstone Biologics N/A -105.99%-87.27% Which has more volatility & risk, UPTD or TSBX? TradeUP Acquisition has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Which has stronger earnings & valuation, UPTD or TSBX? TradeUP Acquisition has higher earnings, but lower revenue than Turnstone Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTradeUP AcquisitionN/AN/A-$1MN/AN/ATurnstone Biologics$19.31M0.42-$55.20M-$3.24-0.11 SummaryTurnstone Biologics beats TradeUP Acquisition on 7 of the 12 factors compared between the two stocks. Remove Ads Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.10M$3.07B$5.64B$8.08BDividend YieldN/A1.47%4.89%4.04%P/E RatioN/A27.6723.7319.00Price / SalesN/A374.75381.75120.61Price / CashN/A168.6838.0534.64Price / Book-0.613.466.904.26Net Income-$1M-$71.72M$3.18B$247.00M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$0.97+7.6%N/A-13.5%$2.10MN/A0.002,021TSBXTurnstone Biologics2.3862 of 5 stars$0.36-2.0%$0.45+23.9%-88.4%$8.40M$19.31M-0.1182Short Interest ↑Gap DownKLTOKlotho NeurosciencesN/A$0.31+0.5%N/AN/A$8.30MN/A0.00N/AGap DownOMGAOmega Therapeutics2.0142 of 5 stars$0.13-21.8%$9.20+7,260.0%-96.9%$6.92M$8.10M-0.09120Gap UpAPTOAptose Biosciences1.9659 of 5 stars$2.98+15.1%$130.00+4,262.4%-92.8%$6.38MN/A-1.0031Short Interest ↑Positive NewsFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+3.3%$5.59M$10.06M-0.6620News CoverageCEROCERo TherapeuticsN/A$1.45+1.0%N/A-99.5%$4.39MN/A0.008TTNPTitan Pharmaceuticals1.5791 of 5 stars$3.97-2.0%N/A-54.9%$3.63M$180,000.000.0010Analyst ForecastShort Interest ↓GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSCNIScinai Immunotherapeutics0.6134 of 5 stars$3.46+3.6%N/A-36.5%$2.95M$452,000.00-0.0120Short Interest ↑Gap DownKRBPKiromic BioPharmaN/A$1.50flatN/A-36.2%$2.31MN/A-0.4360 Remove Ads Related Companies and Tools Related Companies Turnstone Biologics Alternatives Klotho Neurosciences Alternatives Omega Therapeutics Alternatives Aptose Biosciences Alternatives Fresh Tracks Therapeutics Alternatives CERo Therapeutics Alternatives Titan Pharmaceuticals Alternatives Genetic Technologies Alternatives Scinai Immunotherapeutics Alternatives Kiromic BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPTD) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryThe world's central banks are making bold moves—and it's raising eyebrows. What do they know that you don...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPTD Stock Alerts